VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 87 filers reported holding VAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $698,252 | -26.0% | 18,630 | -5.4% | 0.02% | -47.7% |
| Q4 2022 | $944,183 | +124.8% | 19,691 | +12.5% | 0.04% | +238.5% |
| Q3 2022 | $420,000 | +10.2% | 17,504 | -5.0% | 0.01% | +18.2% |
| Q2 2022 | $381,000 | -7.3% | 18,423 | +7.9% | 0.01% | +37.5% |
| Q1 2022 | $411,000 | +1.2% | 17,081 | +7.1% | 0.01% | 0.0% |
| Q4 2021 | $406,000 | -17.3% | 15,954 | -16.3% | 0.01% | -11.1% |
| Q3 2021 | $491,000 | +43.6% | 19,056 | +25.7% | 0.01% | +50.0% |
| Q2 2021 | $342,000 | +17.5% | 15,155 | -2.9% | 0.01% | +20.0% |
| Q1 2021 | $291,000 | -59.5% | 15,606 | -37.0% | 0.01% | -68.8% |
| Q4 2020 | $718,000 | -51.6% | 24,782 | -13.9% | 0.02% | -66.0% |
| Q3 2020 | $1,482,000 | – | 28,778 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
| Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
| RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
| COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
| GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
| ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
| Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
| Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
| BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |